Citi analyst Jason Cassorla maintained a Buy rating on Tenet Healthcare (THC – Research Report) today and set a price target of $171.00. The company’s shares closed yesterday at $145.34.
Cassorla covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Tenet Healthcare, and Surgery Partners. According to TipRanks, Cassorla has an average return of -3.9% and a 54.10% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tenet Healthcare with a $146.69 average price target.
Based on Tenet Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $2.15 billion. In comparison, last year the company earned a revenue of $3 million and had a net profit of $143 million
Based on the recent corporate insider activity of 35 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of THC in relation to earlier this year.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Tenet Healthcare (THC) Company Description:
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities. It operates through the following business segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes operations of USPI joint venture and the company’s nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans, and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.
Read More on THC:
- THC Earnings this Week: How Will it Perform?
- Tenet Healthcare price target raised to $155 from $130 at Truist
- Tenet Healthcare price target raised to $156 from $147 at Barclays
- Uber, Birkenstock among additions to Deutsche Bank ‘Fresh Money List’ for Q3
- Tenet Healthcare price target raised to $155 from $150 at Deutsche Bank
